Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Terminated 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 88INDUSTRY 4NIH 3NETWORK 3FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1CNS 1

Conditions

Respiratory Distress Syndrome 1Pneumonia, Viral 1Pancreatic Neoplasms 1Glioma 1Cytokine Release Syndrome 1

Interventions

Radiotherapy 302Cisplatin 266Cyclophosphamide 230Doxorubicin 177Paclitaxel 170Vincristine 162Carboplatin 152Filgrastim 140Etoposide 139Gemcitabine 118Docetaxel 114Fluorouracil 113Methotrexate 106Dexamethasone 106Cytarabine 106Prednisone 92Leucovorin 90Gene Expression Profiling 82Granulocyte Colony-Stimulating Factor 75Specimen Handling 70Magnetic Resonance Spectroscopy 63Irinotecan 59Capecitabine 59Radiation 54Polymerase Chain Reaction 51Ifosfamide 51Rituximab 49Immunohistochemistry 49Daunorubicin 49Oxaliplatin 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Hydroxychloroquine × Clear all
NCT05518110 2026-04-13

PaTcH

Cancer Trials Ireland

Phase 2 Terminated
20 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04201457 2026-02-03

A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration

Pediatric Brain Tumor Consortium

Phase 1/2 Active not recruiting
57 enrolled
CNS

Glioma

NCT04394182 2022-03-29

ULTRA-COVID

Fundacion GenesisCare

Phase NA Suspended
15 enrolled

Cytokine Release Syndrome, Pneumonia, Viral, Respiratory Distress Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡